# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-14-070778
Filing Date
2014-11-25
Accepted
2014-11-25 07:35:31
Documents
15
Period of Report
2014-11-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | v395164_6k.htm | 6-K | 114687
2 | GRAPHIC | image_001.jpg | GRAPHIC | 2946
3 | GRAPHIC | image_004.jpg | GRAPHIC | 105784
4 | GRAPHIC | image_005.jpg | GRAPHIC | 145842
5 | GRAPHIC | image_006.jpg | GRAPHIC | 178555
6 | GRAPHIC | image_007.jpg | GRAPHIC | 86835
7 | GRAPHIC | image_008.jpg | GRAPHIC | 59529
8 | GRAPHIC | image_009.jpg | GRAPHIC | 129850
9 | GRAPHIC | image_010.jpg | GRAPHIC | 112749
10 | GRAPHIC | image_011.jpg | GRAPHIC | 77788
11 | GRAPHIC | image_012.jpg | GRAPHIC | 113674
12 | GRAPHIC | image_013.jpg | GRAPHIC | 18819
13 | GRAPHIC | image_014.jpg | GRAPHIC | 111716
14 | GRAPHIC | image_015.jpg | GRAPHIC | 160962
15 | GRAPHIC | image_016.jpg | GRAPHIC | 21595
| Complete submission text file | 0001144204-14-070778.txt |  | 1945504

Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 141247785
SIC: 2834 Pharmaceutical Preparations